Smart for Life (SMFL) Competitors $0.0026 0.00 (-58.06%) As of 02:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. MYMD, NCNA, TRVN, CAPS, BON, VINC, UPC, ORGS, NAVB, and SYRSShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include MyMD Pharmaceuticals (MYMD), NuCana (NCNA), Trevena (TRVN), Capstone Therapeutics (CAPS), Bon Natural Life (BON), Vincerx Pharma (VINC), Universe Pharmaceuticals (UPC), Orgenesis (ORGS), Navidea Biopharmaceuticals (NAVB), and Syros Pharmaceuticals (SYRS). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors MyMD Pharmaceuticals NuCana Trevena Capstone Therapeutics Bon Natural Life Vincerx Pharma Universe Pharmaceuticals Orgenesis Navidea Biopharmaceuticals Syros Pharmaceuticals Smart for Life (NASDAQ:SMFL) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations. Which has more volatility & risk, SMFL or MYMD? Smart for Life has a beta of 17.05, meaning that its stock price is 1,605% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. Is SMFL or MYMD more profitable? Smart for Life's return on equity of 0.00% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A MyMD Pharmaceuticals N/A -179.05%-108.14% Which has stronger earnings & valuation, SMFL or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/AMyMD PharmaceuticalsN/AN/A-$4MN/AN/A Does the media favor SMFL or MYMD? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled MyMD Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral MyMD Pharmaceuticals Neutral Do insiders and institutionals believe in SMFL or MYMD? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummarySmart for Life beats MyMD Pharmaceuticals on 6 of the 7 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$3.49B$5.72B$9.77BDividend YieldN/AN/A3.77%4.10%P/E RatioN/A8.4930.9025.26Price / Sales0.0051.53403.8188.28Price / CashN/A5.6225.2228.45Price / Book0.001.179.516.00Net Income-$22.68M$17.44M$3.26B$265.34M7 Day PerformanceN/A9.92%4.48%2.84%1 Month PerformanceN/A10.49%5.19%1.58%1 Year PerformanceN/A-38.17%31.75%25.40% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00-58.1%N/A-99.3%$18K$11.11M0.00110Gap DownMYMDMyMD PharmaceuticalsN/A$0.11+5.7%N/A-94.4%$253KN/A0.006Gap UpHigh Trading VolumeNCNANuCana3.5625 of 5 stars$0.04-4.7%$25.00+61,628.4%-99.5%$248KN/A-0.0130Negative NewsAnalyst UpgradeTRVNTrevena1.1446 of 5 stars$0.25-72.5%$5.00+1,900.0%N/A$240K$443K-0.0140Short Interest ↑Gap DownCAPSCapstone TherapeuticsN/A$1.45+3.6%N/AN/A$232K$44.88M0.0038News CoverageEarnings ReportGap UpBONBon Natural LifeN/A$1.27-2.3%N/AN/A$216K$23.84M0.00100Negative NewsVINCVincerx Pharma2.7171 of 5 stars$0.03+0.3%$40.00+117,547.1%-99.7%$178KN/A0.0060UPCUniverse PharmaceuticalsN/A$3.60+0.1%N/A-99.8%$155K$19.29M0.00220ORGSOrgenesis1.4337 of 5 stars$0.02-80.2%N/AN/A$106K$662K0.00150Short Interest ↑Gap DownNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010SYRSSyros Pharmaceuticals4.3925 of 5 stars$0.00+36.4%$3.33+222,122.2%-99.9%$40K$386K0.00120Short Interest ↓Gap Up Related Companies and Tools Related Companies MyMD Pharmaceuticals Competitors NuCana Competitors Trevena Competitors Capstone Therapeutics Competitors Bon Natural Life Competitors Vincerx Pharma Competitors Universe Pharmaceuticals Competitors Orgenesis Competitors Navidea Biopharmaceuticals Competitors Syros Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access